معرفی
Andrew White is a Clinical Associate Professor and clinician scientist ophthalmologist at the University of Sydney, affiliated with the Save Sight Institute and Westmead Institute for Medical Research. He specializes in glaucoma, holding roles as Head of the Department of Ophthalmology at Westmead Hospital and Director of the Community Eye Care Project (C-eye-C). His research focuses on neuroprotection in glaucoma, mechanisms of disease progression, and improving healthcare delivery through innovative techniques like smartphone-based diagnostics and low-cost surgeries.
Education: B.Med.Sci (Hons) MBBS PhD from the University of Sydney (1995-2001), with postgraduate research at Max Planck Institute and SUNY. Clinical training included subspecialty glaucoma training at Sydney Eye Hospital, Westmead Hospital, and Addenbrooke’s Hospital (UK), where he was a Consultant Ophthalmologist and Senior Lecturer in Ophthalmology (2011).
Research Interests: Neuroprotection strategies, glaucoma pathogenesis, SLT-associated corneal changes, and epidemiology of glaucoma in diverse populations. Active in clinical trials, including renin-angiotensin system modulation and genetic studies (ANZRAG).
Key Awards: 2017 Western Sydney LHD Quality Award, Vision 2020 Rising Stars of Ophthalmology. Leadership roles include Co-chair of the Agency for Clinical Innovation’s Ophthalmology Governing Body, Board Member of Ophthalmic Research Institute of Australia, and advisory roles in global glaucoma organizations.
Publications span neuroprotective agents, surgical innovations (e.g., Hydrus microstent), AI-driven glaucoma screening, and diabetic retinopathy screening programs. Collaborates internationally, notably with the University of Cambridge’s Centre for Brain Repair on neurodegenerative links.
